Rimandeep Kaur
Family · Fresno, CANPI 1811696529
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.1% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,383, more than ten times the $99 reported in 2023.
Across 105 payments — averaging $24.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Daiichi Sankyo Inc.$319
- AstraZeneca$283
- Lilly USA, LLC$188
- Novartis$175
- AbbVie$170
- Exelixis Inc.$146
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,43593%
- Education$1807%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Daiichi Sankyo Inc. | 12 | $319 |
| AstraZeneca | 10 | $283 |
| Lilly USA, LLC | 7 | $188 |
| Novartis | 7 | $175 |
| AbbVie | 7 | $170 |
| Exelixis Inc. | 7 | $146 |
| Ipsen Biopharmaceuticals, Inc | 4 | $114 |
| Merck | 3 | $101 |
| Pharmaessentia USA Corporation | 4 | $87 |
| Stemline Therapeutics Inc. | 2 | $81 |
| Incyte Corporation | 3 | $73 |
| Sobi, Inc | 4 | $72 |
| Sanofi | 2 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $64 |
| Tempus AI, Inc | 2 | $55 |
| Pharmacosmos Therapeutics Inc. | 2 | $53 |
| GSK | 2 | $52 |
| Johnson & Johnson | 2 | $49 |
| Pfizer | 2 | $46 |
| Boehringer Ingelheim | 2 | $44 |
| Servier Pharmaceuticals LLC | 2 | $44 |
| Array Biopharma Inc | 2 | $40 |
| Eisai Inc. | 2 | $39 |
| Nestle Healthcare Nutrition Inc. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Ironshore Pharmaceuticals Inc. | 1 | $23 |
| Deciphera Pharmaceuticals Inc. | 1 | $23 |
| Taiho Oncology, Inc. | 1 | $23 |
| Corium, LLC | 1 | $22 |
| Bristol Myers Squibb | 1 | $21 |
| Bayer | 1 | $20 |
| Novocure Inc. | 1 | $19 |
| Gilead | 1 | $18 |
| Iovance Biotherapeutics, Inc. | 1 | $11 |
How this compares
$2,615 in reported general payments places this provider in the 85th percentile of 10,634 family providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 41 | $776 |
| Ondansetron OdtOndansetron | 14 | $292 |
| Prochlorperazine Maleate | 11 | $173 |
| Potassium Chloride | 14 | $89 |
| Lorazepam | 22 | $35 |
Paid to pharmacies, not to this prescriber.
Other family in Fresno
- Freddy EspinozaFresno$33K
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.